Alzamend Neuro Inc
ALZN | NASDAQ
$1.94
+$0.05 (+2.65%)
At close: Sep 21, 2026, 4:00 PM ET
$1.93
-$0.01 (-0.52%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q1 2027 Jul 30, 2026 | Q4 2026 Apr 29, 2026 | Q3 2026 Jan 30, 2026 | Q2 2026 Oct 30, 2025 | Q1 2026 Jul 30, 2025 | Q4 2025 Apr 29, 2025 | Q3 2025 Jan 30, 2025 | Q2 2025 Oct 30, 2024 | Q1 2025 Jul 30, 2024 | Q4 2024 Apr 29, 2024 | Q3 2024 Jan 30, 2024 | Q2 2024 Oct 30, 2023 | Q1 2024 Jul 30, 2023 | Q4 2023 Apr 29, 2023 | Q3 2023 Jan 30, 2023 | Q2 2023 Oct 30, 2022 | Q1 2023 Jul 30, 2022 | Q4 2022 Apr 29, 2022 | Q3 2022 Jan 30, 2022 | Q2 2022 Oct 30, 2021 | Q1 2022 Jul 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -9.1M | -8.77M | -7.04M | -5.83M | -6.24M | -4.51M | -4.23M | -5.9M | -7.39M | -9.95M | -12.4M | -15.16M | -15.37M | -14.88M | -15.44M | -12.59M | -13.08M | -12.36M | -9.75M | -8.3M | -6.05M |
Depreciation & Amortization | 110.74K | 110.74K | 95.74K | 80.74K | 65.74K | 50.74K | 50.74K | 50.74K | 50.74K | 50.74K | 43.38K | 36.02K | 28.65K | 23.07K | 21.29K | 15.97K | 10.65K | 3.55K | n/a | n/a | n/a |
Stock-Based Compensation | 118.01K | 83.72K | 164.99K | 236.97K | 286.73K | 325.11K | 325.11K | 430.47K | 667.53K | 955.63K | 1.37M | 2.69M | 3.08M | 3.58M | 4.35M | 3.97M | 4.54M | 4.41M | 3.45M | 2.89M | 2.27M |
Other Working Capital | -355.48K | -825.09K | -400.65K | -218.34K | -2.33M | -2.44M | -3.47M | -2.5M | 638.59K | 670.67K | 1.91M | 3.59M | 2.57M | 2.49M | 2.2M | -160.84K | 42.99K | 64.64K | -929.88K | -932.09K | -888.84K |
Other Non-Cash Items | 1.76M | 1.76M | 1.14M | n/a | n/a | 9.29K | 10K | 1.59M | 1.59M | 1.45M | 1.45M | -129.23K | 597.05K | 1.61M | 1.6M | 1.59M | 885.51K | 8.77K | 420.29K | 433.81K | 374.01K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.58M | -1.58M | -1.45M | -1.45M | 129.23K | -597.05K | -1.61M | -1.61M | -1.61M | -881.53K | n/a | n/a | n/a | n/a |
Change in Working Capital | 260.75K | -1.25M | -317.92K | -135.61K | -1.98M | -2.44M | -3.47M | -2.5M | 638.59K | 670.67K | 1.91M | 3.59M | 2.57M | 2.35M | 2.83M | 396.52K | 600.34K | 1.33M | -427.97K | -363.13K | -319.89K |
Operating Cash Flow | -6.84M | -8.07M | -5.96M | -5.65M | -7.88M | -6.57M | -7.31M | -7.91M | -6.03M | -8.27M | -9.08M | -8.85M | -9.68M | -8.92M | -8.25M | -8.23M | -7.93M | -6.61M | -6.31M | -5.33M | -3.73M |
Capital Expenditures | n/a | n/a | -210K | -210K | -210K | -300K | -90K | -90K | -90K | -147.24K | -147.24K | -147.24K | -147.24K | n/a | -106.46K | -106.46K | -106.46K | -106.46K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.8M | 4.8M | 4.8M | 4.8M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | -210K | -210K | -210K | -300K | -90K | -90K | -90K | -147.24K | -147.24K | -147.24K | -147.24K | n/a | -106.46K | -106.46K | -106.46K | 4.69M | 4.8M | 4.8M | 4.8M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 40K | 325.1K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 600 | 600 | 1.17M | 1.17M | 1.47M | 2.62M | 1.47M | 1.47M | 1.17M | 18.29K | 200 | 200 | 3.94M | 3.94M | 3.94M | 3.94M | 1.05M | 1.85M | 1.95M |
Financial Cash Flow | 8.81M | 4.83M | 5.52M | 6.21M | 12.51M | 10.44M | 10.47M | 11.9M | 5.62M | 3.65M | 2.13M | 18.29K | 200 | 200 | 3.94M | 3.94M | 3.94M | 18.85M | 18.06M | 18.9M | 19.28M |
Net Cash Flow | 1.97M | -3.24M | -645K | 356.36K | 4.43M | 3.57M | 3.08M | 3.89M | -501.47K | -4.76M | -7.09M | -8.98M | -9.83M | -8.92M | -4.41M | -4.39M | -4.09M | 12.13M | 11.75M | 13.57M | 15.56M |
Free Cash Flow | -6.84M | -8.07M | -6.17M | -5.86M | -8.09M | -6.87M | -7.4M | -8M | -6.12M | -8.42M | -9.23M | -9M | -9.83M | -8.92M | -8.36M | -8.33M | -8.03M | -6.72M | -6.31M | -5.33M | -3.73M |
Adj. Free Cash Flow | -6.96M | -8.15M | -6.33M | -6.09M | -8.37M | -7.19M | -7.72M | -8.43M | -6.79M | -9.37M | -10.59M | -11.69M | -12.92M | -12.51M | -12.71M | -12.3M | -12.57M | -11.13M | -9.76M | -8.22M | -6M |
Maintenance CapEx | n/a | n/a | -12.69K | -12.69K | -12.69K | -25.37K | -12.69K | -12.69K | -12.69K | -12.69K | -12.69K | -12.69K | -12.69K | n/a | -3.55K | -3.55K | -3.55K | -3.55K | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | -197.32K | -197.32K | -197.32K | -274.63K | -77.32K | -77.32K | -77.32K | -134.56K | -134.56K | -134.56K | -134.56K | n/a | -102.91K | -102.91K | -102.91K | -102.91K | n/a | n/a | n/a |
Owner Earnings | -6.84M | -8.07M | -5.97M | -5.66M | -7.89M | -6.59M | -7.32M | -7.93M | -6.04M | -8.28M | -9.09M | -8.87M | -9.7M | -8.92M | -8.25M | -8.23M | -7.93M | -6.62M | -6.31M | -5.33M | -3.73M |
Add to Watchlist
Select watchlists to add or remove ALZN